Pricing updated 2019-04-23. Prices are subject to change without notice.
17-AAG is an inhibitor of heat shock protein 90 (Hsp90) and a derivative of geldanamycin (Item No. 13355) that selectively inhibits BT474 tumor cell Hsp90 over fibroblast Hsp90 (IC50s = 5 and 943 nM, respectively).1 It inhibits the growth of prostate cancer cell lines (IC50s = 25-45 nM) and promotes the degradation of HER2 and induces growth arrest and apoptosis in breast cancer cells overexpressing HER2 (IC50s = 4-72 nM).2,3 In vivo, 17-AAG (25 mg/kg, i.p.) reduces tumor size in a G-415 gallbladder cancer mouse xenograft model.4
Warning - this product is not for human or veterinary use.
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Kamal, A., Thao, L., Sensintaffar, J., et al. A high-
Solit, D.B., Zheng, F.F., Drobnjak, M., et al. 17-
Münster, P.N., Marchion, D.C., Basso, A.D., et al. Degredation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-
Weber, H., Valbuena, J.R., Barbhuiya, M.A., et al. Small molecule inhibitor screening identifified HSP90 inhibitor 17-